Matugas, Keisha L.
HRN: 19-01-11 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/20/2022
CEFOTAXIME 500MG (VIAL)
05/20/2022
05/27/2022
IV
500 Mg
Q8
PCAP C
Waiting Final Action